Monoclonal Antibody to Domain I of β2-glycoprotein I Prevents the Thrombotic Diathesis Associated With the Antiphospholipid Syndrome

被引:0
|
作者
Lanier, Lane [1 ]
Ulrich, Victoria [1 ]
Tarango, Cristina [1 ]
Yuhanna, Ivan [1 ]
Morrell, Craig N. [2 ]
Shen, Yu-Min [1 ]
Shaul, Philip W. [1 ]
Mineo, Chieko [1 ]
机构
[1] UT SW Med Ctr Dallas, Dallas, TX USA
[2] Univ Rochester, Aab Cardiovasc Rsch Inst, West Henrietta, NY USA
关键词
Thrombosis; Endothelial function; Monoclonal antibodies; Immune system;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
12956
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Research around β2-glycoprotein I:: A major target for antiphospholipid antibodies
    Atsumi, T
    Amengual, O
    Yasuda, S
    Matsuura, E
    Koike, T
    AUTOIMMUNITY, 2005, 38 (05) : 377 - 381
  • [22] Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk
    Krilis, M.
    Qi, M.
    Ioannou, Y.
    Zhang, J. Y.
    Ahmadi, Z.
    Wong, J. W. H.
    Vlachoyiannopoulos, P. G.
    Moutsopoulos, H. M.
    Koike, T.
    Sturgess, A. D.
    Chong, B. H.
    Krilis, S. A.
    Giannakopoulos, B.
    JOURNAL OF AUTOIMMUNITY, 2021, 122
  • [23] The β2-Glycoprotein I/HLA-DR Complex As A Major Autoantibody Target in Obstetric Antiphospholipid Syndrome
    Tanimura, Kenji
    Saito, Shigeru
    Nakatsuka, Mikiya
    Nagamatsu, Takeshi
    Fujii, Tomoyuki
    Fukui, Atsushi
    Deguchi, Masashi
    Sasagawa, Yuki
    Arase, Noriko
    Arase, Hisashi
    Yamada, Hideto
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 (11) : 1882 - 1891
  • [24] Anti-β2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome
    Lopez, LR
    Dier, KJ
    Lopez, D
    Merrill, JT
    Fink, CA
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 121 (01) : 142 - 149
  • [25] β2 glycoprotein I -: A key player in the antiphospholipid syndrome
    Lutters, BCH
    de Groot, PG
    Derksen, RHWM
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2002, 4 (11): : 958 - 962
  • [26] Coexistence of anti-β2-glycoprotein I domain I and anti-phosphatidylserine/prothrombin antibodies suggests strong thrombotic risk
    Lee, Jee-Soo
    Gu, JaYoon
    Park, Hee Sue
    Yoo, Hyun Ju
    Kim, Hyun Kyung
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2017, 55 (06) : 882 - 889
  • [27] Prevalence of antibodies to β2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria:: A single center study and literature review
    Bruce, IN
    Clark-Soloninka, CA
    Spitzer, KA
    Gladman, DD
    Urowitz, MB
    Laskin, CA
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (12) : 2833 - 2837
  • [28] The J-elongated conformation of β2-glycoprotein I predominates in solution: implications for our understanding of antiphospholipid syndrome
    Ruben, Eliza
    Planer, William
    Chinnaraj, Mathivanan
    Chen, Zhiwei
    Zuo, Xiaobing
    Pengo, Vittorio
    De Filippis, Vincenzo
    Alluri, Ravi K.
    McCrae, Keith R.
    Macor, Paolo
    Tedesco, Francesco
    Pozzi, Nicola
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (31) : 10794 - 10806
  • [29] Differential effects of anti-β2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome
    George, J
    Blank, M
    Levy, Y
    Meroni, P
    Damianovich, M
    Tincani, A
    Shoenfeld, Y
    CIRCULATION, 1998, 97 (09) : 900 - 906
  • [30] Fluctuation of Anti-Domain 1 and Anti-β2-Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies
    Chighizola, Cecilia B.
    Pregnolato, Francesca
    Andrade, Danieli
    Tektonidou, Maria
    Pengo, Vittorio
    Ruiz-Irastorza, Guillermo
    Belmont, H. Michael
    Gerosa, Maria
    Fortin, Paul
    Branch, D. Ware
    Andreoli, Laura A.
    Petri, Michelle A.
    Cervera, Ricard S.
    Knight, Jason S.
    Willis, Rohan
    Efthymiou, Maria
    Cohen, Hannah
    Erkan, Doruk
    Bertolaccini, Maria Laura
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 (06) : 984 - 995